Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M E Kraenzlin
Treatment of Patients With Pancreatic Endocrine Tumours Using a New Long-Acting Somatostatin Analogue Symptomatic and Peptide Responses.
Gut
Gastroenterology
Related publications
Somatostatin Analogue Treatment of Neuroendocrine Tumours.
Postgraduate Medical Journal
Medicine
Successful Treatment With a Long-Acting Somatostatin Analogue(SMS201-995) in a Patient With Malignant Carcinoid Syndrome.
Japanese Journal of Medicine
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly
Journal of Endocrinological Investigation
Endocrinology
Metabolism
Diabetes
Glucose Tolerance During Long Term Treatment With a Somatostatin Analogue
BMJ
Somatostatin Analogue Scintigraphy in Carcinoid Tumours
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Long Term Treatment by a Long Acting Somatostatin Analogue (Sms 201–995) in a 4 Months Boy Presenting With Primary Permanent Hyperinsulinism
Pediatric Research
Child Health
Pediatrics
Perinatology
Pharmacokinetic and Pharmacodynamic Properties of a Long-Acting Formulation of the New Somatostatin Analogue, Lanreotide, in Normal Healthy Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours
International Journal of Surgical Oncology
Surgery
Oncology
The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children With Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia
Hormone Research in Paediatrics
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
